A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics

被引:47
作者
Resch, W
Parkin, N
Stuelke, EL
Watkins, T
Swanstrom, R
机构
[1] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biophys, Chapel Hill, NC 27599 USA
[4] ViroLog Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1073/pnas.011511298
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Rapidly evolving entities, such as viruses, can undergo complex genetic changes in the face of strong selective pressure. We have developed a modified heteroduplex tracking assay (HTA) capable of detecting the presence of single, specific mutations or sets of linked mutations. The initial application of this approach, termed multiple-site-specific (MSS) HTA, was directed toward the detection of mutations in the HIV-1 pro gene at positions 46, 48, 54, 82, 84, and 90, which are associated with resistance to multiple protease inhibitors. We demonstrate that MSS HTA is sensitive and largely specific to all targeted mutations. The assay allows the accurate and reproducible quantitation of viral subpopulations comprising 3% or more of the total population. Furthermore, we used MSS HTA in longitudinal studies of pro gene evolution in vitro and in vivo. In the examples shown here, populations turned over rapidly and more than one population was present frequently. To demonstrate the versatility of MSS HTA, we also constructed a probe sensitive to changes at positions 181 and 184 of the RT coding domain. Changes at these positions are involved in resistance to nevirapine and 2',3'-dideoxy-3'-thiacytidine (3TC), respectively. This assay easily detected the evolution of resistance to 3TC. MSS HTA provides a rapid and sensitive approach for detecting the presence of and quantifying complex mixtures of distinct genotypes, including genetically linked mutations, and, as one example, represents a useful tool for following the evolution of drug resistance during failure of HIV-1 antiviral therapy.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 26 条
[1]   DETECTION OF POINT MUTATIONS WITH A MODIFIED LIGASE CHAIN-REACTION (GAP-LCR) [J].
ABRAVAYA, K ;
CARRINO, JJ ;
MULDOON, S ;
LEE, HH .
NUCLEIC ACIDS RESEARCH, 1995, 23 (04) :675-682
[2]   IDENTIFICATION OF DRUG-RELATED GENOTYPIC CHANGES IN HIV-1 FROM SERUM USING THE SELECTIVE POLYMERASE CHAIN-REACTION [J].
ANDERSON, BD ;
SHIRASAKA, T ;
KOJIMA, E ;
YARCHOAN, R ;
MITSUYA, H .
ANTIVIRAL RESEARCH, 1994, 25 (3-4) :245-258
[3]  
Bazar LS, 1999, ELECTROPHORESIS, V20, P1141, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1141::AID-ELPS1141>3.0.CO
[4]  
2-7
[5]   Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].
Cameron, DW ;
Heath-Chiozzi, M ;
Danner, S ;
Cohen, C ;
Kravcik, S ;
Maurath, C ;
Sun, E ;
Henry, D ;
Rode, R ;
Potthoff, A ;
Leonard, J .
LANCET, 1998, 351 (9102) :543-549
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EVOLUTION IN-VIVO TRACKED BY DNA HETERODUPLEX MOBILITY ASSAYS [J].
DELWART, EL ;
SHEPPARD, HW ;
WALKER, BD ;
GOUDSMIT, J ;
MULLINS, JI .
JOURNAL OF VIROLOGY, 1994, 68 (10) :6672-6683
[7]   NONISOTOPIC HYBRIDIZATION ASSAY FOR DETERMINATION OF RELATIVE AMOUNTS OF GENOTYPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ZIDOVUDINE RESISTANCE [J].
EASTMAN, PS ;
BOYER, E ;
MOLE, L ;
KOLBERG, J ;
URDEA, M ;
HOLODNIY, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2777-2780
[8]   SPECIFIC, SENSITIVE, AND RAPID ASSAY FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL MUTATIONS ASSOCIATED WITH RESISTANCE TO ZIDOVUDINE AND DIDANOSINE [J].
FRENKEL, LM ;
WAGNER, LE ;
ATWOOD, SM ;
CUMMINS, TJ ;
DEWHURST, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) :342-347
[9]   THE SAME MUTATION THAT ENCODES LOW-LEVEL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE TO 2',3'-DIDEOXYINOSINE AND 2',3'-DIDEOXYCYTIDINE CONFERS HIGH-LEVEL RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE [J].
GAO, Q ;
GU, ZX ;
PARNIAK, MA ;
CAMERON, J ;
CAMMACK, N ;
BOUCHER, C ;
WAINBERG, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1390-1392
[10]   Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].
Hirsch, MS ;
Conway, B ;
D'Aquila, RT ;
Johnson, VA ;
Brun-Vézinet, F ;
Clotet, B ;
Demeter, LM ;
Hammer, SM ;
Jacobsen, DM ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Vella, S ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991